| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |